<DOC>
	<DOCNO>NCT02993926</DOCNO>
	<brief_summary>The purpose study ass long-term safety efficacy leuprorelin treatment Central Precocious Puberty ( CPP ) Chinese participant .</brief_summary>
	<brief_title>A Study Assess Safety Efficacy Leuprorelin Central Precocious Puberty Among Chinese Participants</brief_title>
	<detailed_description>The drug test study call leuprorelin . Leuprorelin research treat child CPP . This study look long term safety efficacy leuprorelin treatment Chinese participant CPP . The study enroll approximately 300 patient . Participants assign follow group base dose receive per body weight : - Leuprorelin low dose group - Leuprorelin high dose group All participants receive leuprorelin 30 μg/kg &lt; 90 μg/kg 90 μg/kg 180 μg/kg per body weight , injection , subcutaneously , every 4 week least 9 month index period September 1st 1998 September 30th 2017 observe . This multi-center trial conduct China . Data collect period 19 month .</detailed_description>
	<mesh_term>Puberty , Precocious</mesh_term>
	<criteria>1 . Has diagnosis CPP . 2 . Has treat leuprorelin ( Enantone ) least 9 month , stable dose either high dose ( ≥ 90 μg/kg 180 μg/kg ) low dose ( &lt; 90 μg/kg 30 μg/kg ) . 3 . Has initiate complete treatment index period September 1st 1998 September 30th 2017 . 4 . Have follow information prior treatment least one record initiation treatment medical record : height , weight , secondary sexual characteristic base Tanner stag , estradiol testosterone level , follicle stimulate hormone luteinizing hormone level , pelvic ultrasonography female , testicular volume male . 1 . Has treat leuprorelin condition CPP . 2 . Has use gonadotropin release hormone analog ( GnRHa ) product prior initiation leuprorelin therapy switch GnRHa product treatment period . 3 . CPP participant identify etiology , brain tumor cranial irradiation .</criteria>
	<gender>All</gender>
	<minimum_age>N/A</minimum_age>
	<maximum_age>9 Years</maximum_age>
	<verification_date>February 2017</verification_date>
	<keyword>Drug Therapy</keyword>
</DOC>